Massachusetts Financial Services
TARS icon

Massachusetts Financial Services’s Tarsus Pharmaceuticals TARS Stock Holding History

Massachusetts Financial Services’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.9M Sell
405,231
-21,777
-5% -$1.51M 0.01% 564
2026
Q2 		$26.9M Buy
+427,008
New +$27.3M 0.01% 611

Other funds holding TARS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Massachusetts Financial Services's TARS Position: Q3 2026 in Review

Massachusetts Financial Services reduced its Tarsus Pharmaceuticals (TARS) stake by 5.1% in Q3 2026, selling an estimated $1.51M and leaving 405,231 shares worth $31.9M. The position accounts for 0.01% of the portfolio, ranked #564.

Massachusetts Financial Services first reported a position in TARS in Q2 2026 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Massachusetts Financial Services held 405,231 shares of Tarsus Pharmaceuticals worth $31.9M as of Q3 2026.
  • Massachusetts Financial Services sold 21,777 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $1.51M.
  • Tarsus Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #564 holding.
  • Massachusetts Financial Services first reported a position in Tarsus Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.